Market Overview - The pharmaceutical sector experienced a significant surge on July 10, with stocks such as Seer Medical, Lianhuan Pharmaceutical, and Kangchen Pharmaceutical hitting the daily limit [1] - Seer Medical recorded a price of 25.61 with a rise of 10.01%, Lianhuan Pharmaceutical reached 13.62 with a 10.02% increase, and Kangchen Pharmaceutical was at 40.68 with a 10.01% gain [2] Key Events - Merck, a major U.S. pharmaceutical company, announced its intention to acquire UK-based Verona Pharma for approximately $10 billion to enhance its product line for chronic obstructive pulmonary disease (COPD) [3] - Former President Trump threatened to impose a 200% tariff on pharmaceuticals, although this may not take effect immediately, allowing pharmaceutical companies a one-year buffer [3] - The National Healthcare Security Administration and the National Health Commission released measures to support the high-quality development of innovative drugs, including 16 initiatives to enhance support for R&D and encourage clinical application [3] Institutional Insights - The trend of Chinese innovative drugs entering international markets is expected to grow over the next 3-5 years, driven by improved innovation capabilities and profitability of Chinese pharmaceutical companies, which will enhance industry valuation levels [4] - The upstream raw material drug sector has seen a valuation adjustment, now positioned at relatively low levels, with the commercialization of GLP-1 products expected to drive growth in upstream peptide raw materials [4] - As the mid-year reporting period approaches, performance metrics will become a focal point for the market, with expectations for continued improvement in innovative drugs and their supply chains [4]

创新药概念反复走强 塞力医疗8天5板 智通财经7月10日电，创新药概念反复走强，塞力医疗8天5板，联环药业走出4天3板，海思科、华纳药 厂、前沿生物、千红制药等跟涨。消息面上，中金发布研报称，短期ASCO众多临床数据披露，以及三 生为代表的大额BD落地，进一步证实中国创新药开始具备国际化竞争力。下半年ESMO会议的召开， 以及围绕会议前后的数据披露与BD将对创新药有较为积极催化。 ...

Group 1 - The innovative drug concept stocks are experiencing significant activity, with companies like Seer Medical (603716) and Kangchen Pharmaceutical (603590) hitting the daily limit up [1] - Haikang Pharmaceutical (002653) has seen an increase of over 7%, indicating strong market interest [1] - Other companies such as Xianda Co., Ltd. (603086), Warner Pharmaceuticals, and Microchip Biotech are also witnessing upward movements in their stock prices [1]

证券代码：603716 证券简称：塞力医疗 公告编号：2025-061 债券代码：113601 债券简称：塞力转债 公司已按照《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所股票上市规则》 《上市公司募集资金监管规则》等法律法规的要求，制定了《募集资金管理办法》。根据公司的募集资 金管理制度，公司及子公司开设了专门的银行账户对募集资金进行专户存储，并与信达证券股份有限公 司及各开户行分别签署《募集资金专户存储三方监管协议》或《募集资金专户存储四方监管协议》。 （二）募集资金专户开立情况 公司及子公司2018年非公开发行募集资金在专项账户的存续及注销情况如下： 一、2018年非公开发行A股股票募集资金基本情况 经中国证券监督管理委员会核发的《关于核准武汉塞力斯医疗科技股份有限公司非公开发行股票的批 复》（证监许可[2017]2322号）核准，塞力斯医疗科技集团股份有限公司（以下简称"公司"）于2018年 6月5日非公开发行A股股票26,853,709股，每股面值1元，发行价格为每股人民币23.31元，募集资金总额 为625,959,956.79元，扣除各项发行费用后实际募集资金净额人民币607, ...

Summary of Key Points Core Viewpoint - The stock of Sely Medical (603716) experienced a significant increase of 9.86% on the trading day, with a turnover rate of 41.30% and a total transaction value of 1.799 billion yuan, indicating strong market interest and trading activity [2]. Trading Activity - The stock was listed on the Shanghai Stock Exchange's "龙虎榜" due to a daily turnover rate of 40.85%, with a net buying amount of 6.0667 million yuan from brokerage seats [2]. - The top five brokerage seats accounted for a total transaction value of 464 million yuan, with a buying transaction value of 235 million yuan and a selling transaction value of 229 million yuan, resulting in a net buying of 6.0667 million yuan [2]. - The largest buying and selling brokerage was Guotai Junan Securities Co., Ltd. headquarters, with buying amounting to 69.4307 million yuan and selling amounting to 95.7336 million yuan [2]. Historical Performance - Over the past six months, the stock has appeared on the "龙虎榜" 23 times, with an average price increase of 0.93% the day after being listed and an average increase of 3.90% over the following five days [2]. Capital Flow - On the trading day, the stock saw a net inflow of 242 million yuan from major funds, with a net inflow of 171 million yuan from large orders and 70.8008 million yuan from medium orders [2]. - In the past five days, the net inflow of major funds totaled 85.3307 million yuan [2]. Financial Performance - According to the Q1 report released on April 29, the company achieved a revenue of 287 million yuan, representing a year-on-year decline of 40.75%, and reported a net loss of 14.3209 million yuan [2].

| 证券代码：603716 | 证券简称：塞力医疗 | 公告编号：2025-061 | | --- | --- | --- | | 债券代码：113601 | 债券简称：塞力转债 | | 塞力斯医疗科技集团股份有限公司 （二）募集资金专户开立情况 关于注销部分募集资金专项账户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、2018 年非公开发行 A 股股票募集资金基本情况 经中国证券监督管理委员会核发的《关于核准武汉塞力斯医疗科技股份有限 公司非公开发行股票的批复》（证监许可[2017]2322 号）核准，塞力斯医疗科 技集团股份有限公司（以下简称"公司"）于 2018 年 6 月 5 日非公开发行 A 股 股票 26,853,709 股，每股面值 1 元，发行价格为每股人民币 23.31 元，募集资 金总额为 625,959,956.79 元，扣除各项发行费用后实际募集资金净额人民币 607,608,016.80 元。上述资金已于 2018 年 6 月 5 日全部到位，并经中审众环会 计师事务所（特殊普通合伙）于 ...

塞力医疗再度涨停，7个交易日内录得5个涨停，累计涨幅为61.88%，累计换手率为195.11%。截至 11:04，该股今日成交量5835.93万股，成交金额13.23亿元，换手率30.55%。最新A股总市值达44.53亿 元。 龙虎榜数据显示，该股因连续三个交易日内，涨幅偏离值累计达20%、日换手率达20%上榜龙虎榜4 次，买卖居前营业部中，机构净买入8314.44万元，营业部席位合计净买入2.05亿元。 4月29日公司发布的一季报数据显示，一季度公司共实现营业总收入2.87亿元，同比下降40.75%，实现 净利润-0.14亿元，同比下降553.66%。（数据宝） 近日该股表现 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2025.07.08 | -5.95 | 48.82 | -16099.60 | | 2025.07.07 | 6.88 | 45.81 | -6435.20 | | 2025.07.04 | 10.02 | 2.61 | 3220.82 | | 2025.07.03 | 9.99 | 13.40 ...

Core Viewpoint - The innovative drug sector experienced a rebound, with CXO direction leading the gains, as several companies saw significant stock price increases, indicating growing confidence in China's innovative drug capabilities on the international stage [1] Group 1: Market Performance - Companies such as Puris, Medici, Jiuzhitang, Sali Medical, Huanyu Pharmaceutical, and Shanghai Yizhong all reported stock price increases, with Puris rising over 10% and others exceeding 6% [1] Group 2: Industry Insights - CICC released a report highlighting that the recent disclosures of numerous clinical data at ASCO, along with significant business development (BD) deals represented by Sanofi, further confirm the international competitiveness of Chinese innovative drugs [1] - The upcoming ESMO conference and the data disclosures surrounding it are expected to positively catalyze the innovative drug sector [1]

2025.07. 09 【今日推荐】 特朗普称对普京"很不满意" 威胁对俄追加制裁 美国总统特朗普8日表示，已批准向乌克兰运送更多防御性武器，并考虑进一步对俄罗斯实施制裁。 他同时称，对俄罗斯总统普京"很不满意"。特朗普当天在白宫举行的内阁会议上说，普京说过很 多，"态度一直非常好"，但结果"毫无意义"。特朗普表示，他正在考虑是否支持国会参议院正在推进 的一项对俄罗斯实施严厉制裁的新法案。 17 年来首次 法国总统马克龙对英国进行国事访问 当地时间8日，法国总统马克龙开始对英国进行为期三天的国事访问。这是2008年以来法国总统首次 访英，也是自英国正式"脱欧"以来欧盟国家领导人首次访英。英国王储威廉及其妻子凯特王妃前往英 国诺霍特皇家空军基地迎接马克龙及其夫人。根据计划，马克龙将于8日在英国议会发表演讲。10 日，由英国首相斯塔默主持的英法峰会将在唐宁街举行。 日本6 月近1.7 万人中暑紧急送医 创有统计以来新高 当地时间8日，日本总务省消防厅发布消息称，初步统计数据显示，今年6月日本全国共有16943人 因中暑被紧急送医。这一数字创下自2010年开始对6月中暑送医人数进行统计以来的最高值。 【观国内】 国 ...

Group 1 - The U.S. government is considering additional sanctions against Russia and has approved more defensive weapon shipments to Ukraine [2] - Japan reported a record high of 16,943 people hospitalized for heatstroke in June, the highest since records began in 2010 [5] - The National Development and Reform Commission of China announced a new investment of 10 billion yuan to support employment initiatives, aiming to create jobs for 310,000 people [6] Group 2 - France's President Macron is on a state visit to the UK, marking the first visit by a French president since 2008 and the first by an EU leader since Brexit [4] - The Chinese logistics sector saw a significant increase in e-commerce logistics index, reaching a new high of 111.8 points in June [12] - The Chinese government aims to increase the availability of childcare services, targeting 4.5 childcare spots for every 1,000 people by 2025 [8] Group 3 - The China Securities Association is conducting a comprehensive survey of the securities industry to prepare for the upcoming "China Securities Industry Development Report (2025)" [10] - GAC Fiat Chrysler has declared bankruptcy due to an inability to repay debts and lack of assets to cover liabilities [24] - The stock market saw significant movements, with Intel shares rising over 7% while major banks experienced declines [28]